These included: Nausea (36.9 per cent) Fatigue (16.7 per cent) Vomiting (16.3 per cent) Constipation (15.3 per cent) Diarrhoea (12.6 per cent) Study authors added: "Notably, reproductive symptoms (for example, menstrual irregularities) and temperature-related complaints (for example, chills and hot flushes) emerged as unrecognised potential effects
10.3892/etm.2019.7347 107 WangL.LiP.TangZ.YanX.FengB
American Journal of Physiology-Endocrinology and Metabolism, 316 (1), E73-E85
Given the lack of liver GLP-1R expression (136), the potential mechanism of actions of GLP-1R agonists in NASH may be related to the indirect beneficial effects on body weight, IR and reduction in metabolic dysfunction, lipotoxic effects and inflammation (137)
Hypoglycemia is an insulin risk, not typically a GLP-1 risk